Rsb. Williams et al., Loss of a prolyl oligopeptidase confers resistance to lithium by elevationof inositol (1,4,5) trisphosphate, EMBO J, 18(10), 1999, pp. 2734-2745
The therapeutic properties of lithium ions (Li+) are well known; however, t
he mechanism of their action remains unclear. To investigate this problem,
we have isolated Li+-resistant mutants from Dictyostelium, Here, we describ
e the analysis of one of these mutants. This mutant lacks the Dictyostelium
prolyl oligopeptidase gene (dpoA), We have examined the relationship betwe
en dpoA and the two major biological targets of lithium: glycogen synthase
kinase 3 (GSK-3) and signal transduction via inositol (1,4,5) trisphosphate
(IP3), We find no evidence for an interaction with GSK-3, but instead find
that loss of dpoA causes an increased concentration of IP3, The same incre
ase in IP3 is induced in wild-type cells by a prolyl oligopeptidase (POase)
inhibitor. IP3 concentrations increase via an unconventional mechanism tha
t involves enhanced dephosphorylation of inositol (1,3,4,5,6) pentakisphosp
hate, Loss of DpoA activity therefore counteracts the reduction in IP3 conc
entration caused by Li+ treatment. Abnormal POase activity is associated wi
th both unipolar and bipolar depression; however, the function of POase in
these conditions is unclear. Our results offer a novel mechanism that links
POase activity to IP3 signalling and provides further clues for the action
of Li+ in the treatment of depression.